Available Technologies

Filter

Filtered by

Results

Diminished Proteolytic Shedding of Receptor Tyrosine Kinases Mediates MEK Inhibitor Resistance in Triple-Negative Breast Cancer

Technology / Case number: #16742
Aaron Meyer / Miles Miller / Madeleine Oudin / Linda Griffith / Douglas Lauffenburger / Frank Gertler
Technology Areas: Therapeutics
Impact Areas: Healthy Living
Labels
  • Women's Health
License

Extended Transient Transfection by Repeated Delivery of RNA

Technology / Case number: #13415
Matthew Angel / Mehmet Yanik
Technology Areas: Biotechnology / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Surface Binding of Nanoparticles-Based Drug Delivery to Tissue

Technology / Case number: #15731
Rohit N Karnik / Cliff Wong / Ambika Bajpayee / Alan Grodzinsky / Moungi G Bawendi
Technology Areas: Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Nanoparticle Technology for Immune Response Against Small and Macromolecules-Method of Preparation and Uses Thereof

Technology / Case number: #13399J
Frank Alexis / Pamela Basto / Ulrich Von Andrian / Elliot Moseman / Matteo Iannacone / Jinjun Shi / Elena Tonti / Robert Langer / Omid Farokhzad
Technology Areas: Chemicals & Materials / Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Glycan-Receptor Binding of the Novel Influenza A Virus H7N9 Hemagglutinin

Technology / Case number: #16359
Akila Jayaraman / Kannan Tharakaraman / Nathan Stebbins / Rahul Raman / Ram Sasisekharan
Technology Areas: Diagnostics / Therapeutics
Impact Areas: Healthy Living
License

Brd4 as a Prognostic Indicator and Modulator of the Cell Response to DNA Damage

Technology / Case number: #15011
Scott Floyd / Michael Yaffe
Technology Areas: Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Inhibition of Histone Deacetylase 2 Facilitates Extinction of Aversive Memory

Technology / Case number: #13759HBJRQ
Li-Huei Tsai / Stephen Haggarty / Jisong Guan / Edward Holsen / Florence Wagner / Johannes Graff
Technology Areas: Therapeutics
Impact Areas: Healthy Living
License

Programmable Gene Insertion with Paired Targeting Guides

Technology / Case number: #24104
Omar Abudayyeh / Jonathan S. Gootenberg
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living
License

Synergistic Tumor Treatment with Extended-PK IL-2 & Monoclonal Antibodies

Technology / Case number: #15627
Shuning (Annie) Gai / Byron Kwan / Karl Dane Wittrup
Technology Areas: Therapeutics
Impact Areas: Healthy Living
License

Vaccine Nanotechnology and Uses Thereof

Technology / Case number: #12788J
Frank Alexis / Liangfang Zhang / Pamela Basto / Ulrich Von Andrian / Tobias Junt / Elliot Moseman / Matteo Iannacone / Robert Langer / Omid Farokhzad
Technology Areas: Chemicals & Materials / Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Universal RNA-Binding Protein Based on the Pumilio Domain Architecture

Technology / Case number: #17629TE
Edward Stuart Boyden / Katarzyna Adamala / Daniel Martin Alarcon
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living
License

Biomarkers and Therapeutics for Autism Spectrum Disorders

Technology / Case number: #13589P
Damon Page / Mriganka Sur
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living
License

Generation of Specialized, High-Value Cells and Tissues from Human Induced Pluripotent Stem Cells by Recapitulating Early Embryogenesis Using Gata Factor-Induced Endoderm

Technology, Tangible Property / Case number: #16205
Ron Weiss / Patrick Guye / Mohammad Reza Ebrahimkhani
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living
License

Method for High Efficiency in Vivo Gene Editing

Technology / Case number: #17117H
Wen Xue / Joseph Dorkin / Hao Yin / Tyler Jacks / Daniel Anderson
Technology Areas: Biotechnology / Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Highly Parallel Profiling of Enzymes In Vivo Using Mass-Encoded Substrate Libraries

Technology / Case number: #13062
Geoffrey Von Maltzahn / Gabriel Kwong / Sangeeta Bhatia
Technology Areas: Biotechnology / Diagnostics / Therapeutics
Impact Areas: Healthy Living
License

Programmable Drug Delivery Profiles of Tumor-Targeted Bacteria

Technology / Case number: #15818H
Tal Danino / Sangeeta Bhatia
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living
License

High-Throughput Screening Metabolic Flux Biosensor

Technology / Case number: #16813JW
Jose Avalos / Gregory Stephanopoulos / Gerald Fink
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living
License

Epigenetic Mechanisms Re-Establish Access to Long-Term Memory After Neuronal Loss

Technology / Case number: #12467HPBJ
Weiping Tang / Andre Fischer / Li-Huei Tsai / Stephen Haggarty / Stuart Schreiber
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living
License

In Vivo Targeting of T-Cells with Antibody- and Cytokine Conjugated Liposomes

Technology / Case number: #16405H
Yiran Zheng / Yuan Zhang / Brandon Kwong / Darrell J Irvine
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living
License

Bacteriophage Host Range Engineering

Technology / Case number: #16347
Timothy K Lu / Hiroki Ando / Sebastien Lemire
Technology Areas: Biotechnology / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

The technologies listed represent a selection of the MIT intellectual property protected by the TLO.

filtered: 351 results

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

Sign Up